Catalysts for Tecentriq
41 tracked
Apr 30, 2026
phase 2 completion
Arcus Biosciences Inc — atezolizumab (Phase II Trial Completion)
atezolizumab
→
Apr 29, 2026
phase 0 trial completion
Dana-Farber Cancer Institute Inc — atezolizumab (Phase 0 Trial Completion)
atezolizumab
→
Nov 17, 2025
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
Oct 2, 2025
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
Aug 18, 2025
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
Apr 22, 2024
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
May 12, 2023
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
May 12, 2023
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
Dec 9, 2022
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
Dec 2, 2022
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
Jan 21, 2022
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
Oct 15, 2021
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
Oct 6, 2021
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
Apr 13, 2021
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
Feb 17, 2021
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
Feb 17, 2021
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
Feb 17, 2021
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
Feb 17, 2021
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
Feb 17, 2021
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
Feb 17, 2021
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
Dec 18, 2020
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
Dec 18, 2020
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
Nov 10, 2020
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
Sep 30, 2020
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
Jul 30, 2020
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
May 29, 2020
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
May 18, 2020
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
Dec 3, 2019
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
May 6, 2019
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
May 6, 2019
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→